Introduction {#sec1_1}
============

Primary (amyloid light-chain or AL) amyloidosis of the gastrointestinal (GI) tract is rare, with biopsy-diagnosed disease and clinically apparent disease occurring in 8 and 1% of patients, respectively \[[@B1]\]. In the GI tract, amyloidosis affects the duodenum most commonly, followed by the stomach and colorectum. GI bleeding due to AL amyloidosis is a rare phenomenon, and has been reported in 10--40% of patients with GI involvement \[[@B2], [@B3]\]. Other clinical manifestations of GI amyloidosis include abdominal pain, gastroesophageal reflux disease-like symptoms, nausea, gastroparesis, food retention, intestinal obstruction (and pseudo-obstruction), malabsorption, bacterial overgrowth, and diarrhea \[[@B3]\]. Such symptoms in patients with known plasma cell dyscrasias should prompt consideration of amyloidosis in the differential diagnosis. Simultaneous gastric and colonic involvement causing substantial upper and lower GI tract bleeding has never been reported in AL amyloidosis.

Case Report {#sec1_2}
===========

A 67-year-old lady known to have multiple myeloma and AL amyloidosis presented with massive upper GI bleeding and was admitted to the medical intensive care unit. She was found to have an elevated international normalized ratio of 1.8 and was on rivaroxaban for atrial fibrillation. An emergent esophagogastroduodenoscopy was done, which showed a greater curvature mass at the distal body and proximal antrum with active bleeding. There was a submucosal hematoma around the mass, and the size of the mass was 3 × 7 cm (Fig. [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, [3](#F3){ref-type="fig"}).

The patient received 10 units of packed red blood cells for resuscitation from hemorrhagic shock. She underwent angiography of the mesenteric vasculature for arterial embolization. The angiogram was interpreted as normal, and no bleeder could be identified. In the meantime, her hemoglobin level remained stable. The decision was made to proceed with the wedge resection of the mass which was the source of the bleeding, as the patient wished to continue anticoagulation for atrial fibrillation in the future. She underwent partial gastrectomy, and the gastric tissue was sent for histopathological examination. The gastric tissue was found to have amyloid deposition consistent with gastric amyloidosis (Fig. [4](#F4){ref-type="fig"}).

The patient did well after surgery and was discharged home on rivaroxaban. She presented again 4 weeks after discharge with complaint of bleeding per rectum. Colonoscopy was performed, which revealed a large mass with an overlying clot and fresh bleeding in the proximal transverse colon (Fig. [5](#F5){ref-type="fig"}).

Biopsy of the mass revealed amyloid deposition. At this point of time, the decision was made to treat her conservatively because of her general condition and wishes. Her hemoglobin level then remained stable and the bleeding per rectum stopped, so she was discharged home. Upon discharge, rivaroxaban was stopped. She recovered well and had no further episodes of GI bleeding on follow-up.

Discussion {#sec1_3}
==========

Amyloidosis is a condition of extracellular fibrillar protein deposition that is commonly associated with tissue injury and dysfunction \[[@B4]\]. Primary amyloidosis usually represents amyloidosis associated with immunocyte dyscrasia from monoclonal proliferation of plasma cells that synthesize an immunoglobulin that is prone to form amyloid. GI amyloidosis can occur as an isolated entity or as part of multisystemic involvement. Different types of amyloid proteins can deposit in various parts of the GI tract or liver, manifesting as abdominal pain, GI dysmotility, diarrhea, GI bleeding, or hepatic injury \[[@B5]\].

Amyloidosis of the GI tract presenting with massive GI bleeding is extremely rare and is thought to be related to small-vessel fragility due to amyloid infiltration and impaired hemostasis caused by factor X deficiency \[[@B6]\]. In the stomach, gastric amyloidosis may have an endoscopic appearance mimicking gastric neoplasia \[[@B7], [@B8]\], hematomas, erosions and ulcerations, or a nodular gastritis \[[@B9]\]. Amyloidosis of the GI tract can appear as submucosal tumors, polyps, antral narrowing, thickened irregular gastric folds, or loss of rugal folds. Other appearances include gastric ulcers, hematomas, arteriovenous malformations, granularly appearing mucosa, plaque-like lesions, or ulcerative gastritis, often associated with GI bleeding \[[@B10]\].

The pathophysiology of GI bleeding from amyloidosis involves local ischemia, infarction, and mucosal injury which cause erosions, hematomas, or ulcerations. Submucosal hematoma as reported in this case has been described as a distinctive feature of GI amyloidosis on endoscopy and can be seen along the entire length of the GI tract \[[@B3], [@B11]\]. The reported size of the hematoma can vary from a few millimeters to several centimeters. Submucosal hematomas can expand rapidly, leading to life-threatening complications. A giant submucosal hematoma of the gastric fundus with rapid expansion resulting in emergent gastrectomy has been reported in the literature \[[@B12]\]. Hematoma rupture in patients with gastric amyloidosis can sometimes cause life-threatening GI bleeding. Endoscopic hemostasis is often ineffective, and other treatment modalities such as surgical intervention or arterial embolization may be needed \[[@B13]\].

Our patient was on anticoagulation, and this was likely to have triggered the GI bleed in her case, since she did not report any further episodes after anticoagulation had been discontinued. Even though GI bleeding in amyloidosis is spontaneous, use of anticoagulation could activate such episodes in these patients. Caution should be exercised with the use of anticoagulation in patients with amyloidosis involving the GI tract. There is no current guideline, but after having found a gastric amyloid lesion, colonoscopy should also be considered for any other amyloid lesion, as was found in our case.
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![Esophagogastroduodenoscopic image of the gastric mass with submucosal hemorrhage.](crg-0011-0625-g02){#F2}

![Another view of the gastric mass with a submucosal hematoma and active bleeding.](crg-0011-0625-g03){#F3}

![The muscularis propria is disrupted by an amorphous, weakly eosinophilic, acellular material (amyloid). HE. ×200.](crg-0011-0625-g04){#F4}

![Colonoscopic image of the transverse colon showing a large bleeding mass with an endoclip.](crg-0011-0625-g05){#F5}
